We produced and tested 8 rAbs from primary progressive MS patient MS02-19, who demonstrated a high CSF PLP1–specific antibody titer (G/R ratio = 1.3, Supplemental Figure 8). This evidence concerns the gene PLP1 and primary progressive multiple sclerosis.